GB2587997A - A semisynthetic method of preparing neosaxitoxin - Google Patents
A semisynthetic method of preparing neosaxitoxin Download PDFInfo
- Publication number
- GB2587997A GB2587997A GB2018189.7A GB202018189A GB2587997A GB 2587997 A GB2587997 A GB 2587997A GB 202018189 A GB202018189 A GB 202018189A GB 2587997 A GB2587997 A GB 2587997A
- Authority
- GB
- United Kingdom
- Prior art keywords
- solution
- extract
- volume
- gtx1
- isolate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/12—Unicellular algae; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/12—Unicellular algae; Culture media therefor
- C12N1/125—Unicellular algae isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M21/00—Bioreactors or fermenters specially adapted for specific uses
- C12M21/02—Photobioreactors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/14—Bags
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/22—Transparent or translucent parts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/06—Nozzles; Sprayers; Spargers; Diffusers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/26—Means for regulation, monitoring, measurement or control, e.g. flow regulation of pH
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/02—Separating microorganisms from the culture medium; Concentration of biomass
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/89—Algae ; Processes using algae
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
A semisynthetic method of preparing neosaxitoxin in quantities of a purity sufficient to allow the compound to be used as an active pharmaceutical ingredient (API) is described. The scalable method includes the reductive desulfonation of an unresolved mixture of gonyautoxin 1 (GTX1) and gonyautoxin 4 (GTX4) isolated from an extract of a culture of Alexandrium pacificum grown to high cell densities in aerated vertical columns of amended sea water.
Claims (10)
1) A method of preparing a quantity of neoSTX comprising the steps of: (a) contacting in solution in a reaction solvent a quantity of purified GTX1,4 and a quantity of dithiol for a period of time and at a temperature sufficient to provide a reaction product in which greater than 97.5% (w/w) of the GTX1,4 has been converted to neoSTX; and then (b) applying the reaction product to a silica based weak cation exchange sorbent and eluting with an aqueous weak organic acid to separate the neoSTX from the dithiol and provide the quantity of neoSTX, where the pH of the solution is in the range 7.4 to 7.6.
2) The method of claim 1 where the reaction solvent is buffered aqueous acetic acid.
3) The method of claim 1 or 2 where the dithiol is selected from the group consisting of dithiothreitol (DTT) and dithiobutylamine (DTBA) .
4) The method of claim 1 where the dithiol is dithiothreitol (DTT) .
5) A method of fractionating a volume of concentrated aqueous extract to provide a solution of partially purified GXT1,4 comprising the steps: (a) Reducing the volume of the aqueous extract by ultrafiltration to provide a reduced volume; (b) Loading the reduced volume on a column of activated carbon sorbent to provide a loaded column; and (c) Eluting the loaded column with a stepwise gradient of water followed by aqueous acetic acid/acetonitrile to provide the solution of partially purified GTX1,4, where the volume of concentrated aqueous extract is an extract of a culture of a dinoflagellate .
6) A method of preparing a volume of concentrated aqueous extract for use in the preparation of a quantity of GTX1,4 comprising the steps: (a) Culturing a selected isolate of a dinoflagellate in a vertical column of aerated amended seawater for a period of time and at a temperature sufficient to provide a culture having a predetermined cell density; (b) Harvesting the cells from the culture having the predetermined cell density to provide a quantity of cellular biomass; (c) Resuspending the quantity of cellular biomass in an aqueous solution of a weak organic acid for a period of time and at a temperature sufficient to provide a mixture of residual biomass and an extract in solution; (d) Separating the residual biomass from the extract in solution; and then (e) Reducing the volume of the extract in solution to provide the volume of concentrated aqueous extract, where the selected isolate has been selected to produce a ratio of GTX2,3 to GTX1,4 of less than 0.1, the amended seawater is seawater amended with a nutrient medium, and the predetermined cell density is in the range 7 x 104 to 105 cells/mL.
7) The method of claim 6 where the selected isolate is an isolate of the dinoflagellate Alexandrium pacificum.
8) The method of claim 7 where the isolate is an isolate of the dinoflagellate Alexandrium pacificum that produces a ratio of GTX2,3 to GTX1,4 of less than 0.01.
9) The method of any one of claims 6 to 8 where the aqueous solution of a weak organic acid is 0.25 to 0.75% acetic acid.
10) A quantity of neoSTX having a purity greater than 99.5% (w/w) where the quantity is greater than 100 mg.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2018/057274 WO2020058750A1 (en) | 2018-09-21 | 2018-09-21 | A semisynthetic method of preparing neosaxitoxin |
Publications (3)
Publication Number | Publication Date |
---|---|
GB202018189D0 GB202018189D0 (en) | 2021-01-06 |
GB2587997A true GB2587997A (en) | 2021-04-14 |
GB2587997B GB2587997B (en) | 2023-05-10 |
Family
ID=69888393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2018189.7A Active GB2587997B (en) | 2018-09-21 | 2018-09-21 | A semisynthetic method of preparing neosaxitoxin |
Country Status (8)
Country | Link |
---|---|
US (2) | US10822344B2 (en) |
JP (1) | JP7110403B2 (en) |
CN (1) | CN113166164B (en) |
CA (1) | CA3113727A1 (en) |
CL (1) | CL2020003015A1 (en) |
GB (1) | GB2587997B (en) |
SG (1) | SG11202102830SA (en) |
WO (2) | WO2020058750A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3113727A1 (en) * | 2018-09-21 | 2020-03-26 | The Cawthron Institute Trust Board | A semisynthetic method of preparing neosaxitoxin |
US12018034B2 (en) | 2018-09-21 | 2024-06-25 | The Cawthron Institute Trust Board | Semisynthetic methods of preparing GTX1,4 and neosaxitoxin |
CN112461913B (en) * | 2020-11-06 | 2022-02-22 | 华南农业大学 | Method for improving identification capability of isomer compound |
FR3130842A1 (en) | 2021-12-22 | 2023-06-23 | CarbonWorks | METHOD FOR CAPTURING PHYTOTOXINS IN A BIOLOGICAL REACTOR |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003012699A (en) * | 2001-07-04 | 2003-01-15 | Japan Science & Technology Corp | Method for manufacturing anti-paralytic shellfish poison antibody, new antibody, elisa measuring kit using the antibody, and system-labeling poison standard sample prepared by the manufacturing method |
JP2006098293A (en) * | 2004-09-30 | 2006-04-13 | Japan Science & Technology Agency | Method for transforming paralytic shellfish poisoning component |
US8952152B2 (en) * | 2009-03-24 | 2015-02-10 | Proteus S.A. | Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof |
CL2009000723A1 (en) * | 2009-03-24 | 2009-06-19 | Proteus Sa | Industrial purification method of biologically active phycotoxins comprising providing an adequate amount of a source of phycotoxins such as the cultivation of a cyanobacterial clone. |
JP6422814B2 (en) * | 2015-04-16 | 2018-11-14 | 学校法人北里研究所 | Method for producing decarbamoyl saxitoxin and its analogs |
CA3113727A1 (en) * | 2018-09-21 | 2020-03-26 | The Cawthron Institute Trust Board | A semisynthetic method of preparing neosaxitoxin |
-
2018
- 2018-09-21 CA CA3113727A patent/CA3113727A1/en active Pending
- 2018-09-21 WO PCT/IB2018/057274 patent/WO2020058750A1/en active Application Filing
- 2018-09-21 GB GB2018189.7A patent/GB2587997B/en active Active
-
2019
- 2019-09-23 JP JP2020567588A patent/JP7110403B2/en active Active
- 2019-09-23 CN CN201980055613.6A patent/CN113166164B/en active Active
- 2019-09-23 WO PCT/IB2019/058019 patent/WO2020058949A1/en unknown
- 2019-09-23 SG SG11202102830SA patent/SG11202102830SA/en unknown
-
2020
- 2020-05-01 US US16/865,027 patent/US10822344B2/en active Active
- 2020-09-11 US US17/018,816 patent/US11028094B2/en active Active
- 2020-11-19 CL CL2020003015A patent/CL2020003015A1/en unknown
Non-Patent Citations (12)
Title |
---|
"CRM-NEO-c available from the National Research Council Canada", CRM-NEO-c is a certified calibration solution designed for use in chemical analysis methods, (20160122), URL: https://www.nrc-cnrc.gc.ca/eng/solutions/advisory/crm/list_product.html, (20181214) [X] 10 * as per the Wayback Machine see w * |
CHO, Y. et al., "Column switching combined with hydrophilic interaction chromatography-tandem mass spectrometry for the analysis of saxitoxin analogues, and their biosynthetic intermediates in dinoflagellates", Journal of Chromatography A, (20160000), vol. 1474, doi:10.1016/j.chroma.2016.10.065, pag * |
HWANG, D. F. et al., "Influence of environmental and nutritional factors on growth, toxicity, and toxin profile of dinoflagellate Alexandrium minutum", Toxicon, (20000000), vol. 38, pages 1491 - 1503 * see Materials and methods * * |
LAYCOCK, M. V. et al., "Some in vitro chemical interconversions of paralytic shellfish poisoning (PSP) toxins useful in the preparation of analytical standards", Journal of Marine Biotechnology (Proceedings of the Third International Marine Biotechnology Conference, (19940000), vol. 3, no. 1-3, page * |
LIM, P-T. et al., "Growth and toxin production of tropical Alexandrium minutum Halim (Dinophyceae) under various nitrogen to phosphorus ratios", Journal of Applied Phycology, (20100000), vol. 22, pages 203 - 210, * see Materials and Methods; Table 1; Figure la; p. 206 Toxins * * |
MIROCHA, C. J. et al., Analysis of saxitoxin from urine using FAB/MS Midterm Report, 1919 University Avenue St. Paul , Minnesota 55105, (19900731),* see page 33 * * |
PARKER, N. S. et al., "Growth of the toxic dinoflagellate Alexandrium minutum (Dinophyceae) using high biomass culture systems", Journal of Applied Phycology, (20020000), vol. 14, pages 313 - 324, * see p. 315 Growth in aerated tubes * * |
PEAKE, R. W. A. et al., "Measurement of neosaxitoxin in human plasma using liquid- chromatography tandem mass spectrometry: Proof of concept for a pharmacokinetic application", Journal of Chromatography B, (20160000), vol. 1036 - 1, doi:10.1016/j.jchromb.2016.09.043, pages 42 - 49, see 2.1, 2.3 * |
SAKAMOTO, S. et al., "Formation of intermediate conjugates in the reductive transformation of gonyautoxins to saxitoxins by thiol compounds", Fisheries Science, (20000000), vol. 66, pages 136 - 141 * |
SATO, S. et al., "Identification of Thioether Intermediates in the Reductive Transformation of Gonyautoxins in Saxitoxins by Thiols", Bioinorganic & Medicinal Chemistry Letters, (20000000), vol. 10, doi:10.1016/S0960-894X(00)00332-2, pages 1787 - 1789 * |
WANG, D-Z. et al., "Toxin composition variations in cultures of Alexandrium species isolated from the coastal waters of southern China", Harmful Algae, (20050000), vol. 4, doi:10.1016/j.hal.2003.12.003, pages 109 - 121, * see 2.2, 3.1 * * |
ZITTELLI, G. C. et al., "Productivity and photosynthetic efficiency of outdoor cultures of Tetraselmis suecica in annular columns", Aquaculture, (20060000), vol. 261, doi:10.1016/j.aquaculture.2006.08.011, pages 932 - 943, * see Fig. 2 * * |
Also Published As
Publication number | Publication date |
---|---|
SG11202102830SA (en) | 2021-04-29 |
JP7110403B2 (en) | 2022-08-01 |
CN113166164B (en) | 2024-01-30 |
WO2020058949A1 (en) | 2020-03-26 |
US11028094B2 (en) | 2021-06-08 |
WO2020058750A1 (en) | 2020-03-26 |
GB202018189D0 (en) | 2021-01-06 |
CA3113727A1 (en) | 2020-03-26 |
US20200407367A1 (en) | 2020-12-31 |
GB2587997B (en) | 2023-05-10 |
JP2021526539A (en) | 2021-10-07 |
CL2020003015A1 (en) | 2021-06-25 |
US10822344B2 (en) | 2020-11-03 |
CN113166164A (en) | 2021-07-23 |
US20200255441A1 (en) | 2020-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2587997A (en) | A semisynthetic method of preparing neosaxitoxin | |
Han et al. | High‐level production of microbial prodigiosin: A review | |
ES2965637T3 (en) | Procedure for the production of ortho-aminobenzoic acid and/or aniline by recombinant yeast | |
Dai et al. | Sugaring-out extraction of 2, 3-butanediol from fermentation broths | |
CN103459032B (en) | Liquid cation exchanger | |
Czarnotta et al. | Fermentation and purification strategies for the production of betulinic acid and its lupane‐type precursors in Saccharomyces cerevisiae | |
Lang et al. | Production of ectoine through a combined process that uses both growing and resting cells of Halomonas salina DSM 5928 T | |
UA66368C2 (en) | Additives to combined feeds containing d-panthotenic acid and/or salts thereof, and a method of obtaining thereof (variants) | |
Morgunov et al. | Biosynthesis of isocitric acid in repeated-batch culture and testing of its stress-protective activity | |
CN109020943B (en) | Antituberculous polyketone compound and preparation method and application thereof | |
Kanzaki et al. | A Novel Potent Cell Cycle Inhibitor Dehydrophenylahistin Enzymatic Synthesis and Inhibitory Activity toward Sea Urchin Embryo | |
Trotsenko et al. | Biotechnological potential of aerobic methylotrophic bacteria: a review of current state and future prospects | |
CN110330544B (en) | 4,4, 1-bicyclic steroid compound and preparation method and application thereof | |
Kobelt et al. | The L‐form of N‐7‐mercaptoheptanoyl‐O‐phosphothreonine is the enantiomer active as component B in methyl‐CoM reduction to methane | |
Ayadi et al. | The saltern-derived Paludifilum halophilum DSM 102817 T is a new high-yield ectoines producer in minimal medium and under salt stress conditions | |
TW201734198A (en) | Mutant of corynebacterium glutamicum producing L-histidine and method for producing l-histidine using the same | |
Salas et al. | Production of the dinoflagellate Amphidoma languida in a large scale photobioreactor and structure elucidation of its main metabolite AZA-39 | |
CN106432169A (en) | Isocoumarin compound with anti-vibrio activity function and crystal thereof | |
JPH06189781A (en) | Stabilization of bioactive protein in culture solution | |
Izumi et al. | Incorporation of the sulfur of L-[35S] methionine into the biotin molecule by intact cells of Rhodotorula glutinis | |
CN116874417B (en) | Pyridine alkaloid and application thereof in preparation of antitumor drugs | |
WO2018166899A1 (en) | Methods for production of pf1022a derivatives | |
Řeháček | Biotechnology of ergot alkaloids | |
US12018034B2 (en) | Semisynthetic methods of preparing GTX1,4 and neosaxitoxin | |
CN108822119B (en) | Erythronolide ketone compound with autophagy activation activity, preparation method and pharmaceutical application thereof |